Abstract
It is rare for a study to address immediate metabolic change in pre-eclamptic pregnancy. Our aim is to study the ante-partum and post-partum metabolic markers in pre-eclampsia. A total of 33 pre-eclamptic and 200 uncomplicated women with singleton pregnancies were recruited for the prospective research. Immediately ante-partum and 24–48 h postpartum venous blood samples were collected for the analysis of metabolic markers. In the pre-eclamptic group, the ante-partum fasting glucose, fasting insulin, triglyceride and free fatty acid levels were found to be higher than in the control group; however, ante-partum high-density lipoprotein level was lower. Interestingly, fasting glucose and insulin levels decreased by 24–48 h post-partum in both groups and no significant differences were found. Pre-eclamptic patients had lower post-partum high-density lipoprotein (P=0.02), higher triglyceride (P<0.001), higher free fatty acid (P=0.02) and higher apolipoprotein B levels (P=0.01) than the control group. Dyslipidemia lasts from ante-partum to immediate post-partum in pre-eclamptic women in the form of increased triglyceride, higher free fatty acid and decreased high-density lipoprotein levels. We speculate that women with dyslipidemia and higher baseline blood pressure tend to develop pre-eclampsia during pregnancy. Hence, the development of pre-eclampsia may be a ‘marker’ of possible future cardiovascular or metabolic disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bonney EA . Preeclampsia: a view through the danger model. J Reprod Immunol 2007; 76: 68–74.
ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33. Int J Gynecol Obstet 2002; 77: 67–75.
Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002; 186: 66–71.
Harskamp RE, Zeeman GG . Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 2007; 334: 291–295.
Yücesoy G, Ozkan S, Bodur H, Tan T, Cali°kan E, Vural B et al. Maternal and prenatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet 2005; 273: 43–49.
McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ . Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156: 918–930.
Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ . Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53: 944–951.
Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ . Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009; 40: 1176–1180.
Villa PM, Laivuori H, Kajantie E, Kaaja R . Free fatty acid profiles in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 17–21.
Soonthornpun K, Soonthornpun S, Wannaro P, Setasuban W, Thamprasit A . Insulin resistance in women with a history of severe pre-eclampsia. J Obstet Gynaecol Res 2009; 35: 55–59.
Isezuo SA, Ekele BA . Comparison of metabolic syndrome variables among pregnant women with and without eclampsia. J Natl Med Assoc 2008; 100: 1059–1162.
Yen SSE . Endocrine regulation of metabolic homeostasis during pregnancy. Clin Obstet Gynecol 1973; 16: 130–147.
Bodnar LM, Ness RB, Markovic N, Roberts JM . The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15: 475–482.
Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200: 58. e1–e8.
Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM . Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 1996; 174: 975–982.
Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T et al. Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 2006; 70: 768–772.
Barbieri RL . Endocrine disorders in pregnancy. In: Yen SSC, Jaffe RB, Barbieri RL (eds). Reproductive Endocrinology. WB Saunders Co: Philadelphia, PA, 1999.
Rademacher TW, Gumaa K, Scioscia M . Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder. J Reprod Immunol 2007; 76: 78–84.
Masuyama H, Nakatsukasa H, Takamoto N, Hiramatsu Y . Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. J Clin Endocrinol Metab 2007; 92: 2672–2679.
Girouard J, Giguère Y, Moutquin JM, Forest JC . Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007; 49: 1056–1062.
Roberts JM, Gammill H . Insulin resistance in preeclampsia. Hypertension 2006; 47: 341–342.
Potter JM, Nestel PJ . The hyperlipidemia of pregnancy in normal and complicatedpregnancies. Am J Obstet Gynecol 1979; 33: 165–170.
Herrera E, Lasuncion MA, Gomez-Coronado D, Aranda P, Lopez-Luna P, Maier I . Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol 1988; 158: 1575–1583.
Laivuori H, Tikkanen MJ, Ylikorkala O . Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81: 2908–2911.
Ray JG, Diamond P, Singh G, Bell CM . Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006; 113: 379–386.
Villa PM, Laivuori H, Kajantie E, Kaaja R . Free fatty acid profiles in preeclampsia. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 17–21.
Endresen J, Lorentzen B, Henriksen T . Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992; 167: 440–447.
Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsh J et al. Serum levels of the adipokineadipocyte fatty-acid-binding protein are increased in preeclampsia. Am J Hypertens 2008; 21: 582–586.
Kajantie E, Kaaja R, Ylikorkala O, Andersson S, Laivuori H . Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity. J Soc Gynecol Investig 2005; 12: 433–439.
Sharma A, Satyam A, Sharma JB . Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007; 58: 21–30.
Clausen T, Djurovic S, Henriksen T . Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG 2001; 108: 1081–1087.
Edlow AG, Srinivas SK, Elovitz MA . Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2009; 200: e60–e62.
Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE . Preeclampsia—a state of sympathetic overactivity. N Engl J Med 1996; 335: 1480–1485.
Bartha JL, González-Bugatto F, Fernández-Macías R, González-González NL, Comino-Delgado R, Hervías-Vivancos B . Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 2008; 137: 178–184.
Ray JG, Vermeulen MJ, Schull MJ, McDonald S, Redelmeier DA . Metabolic syndrome and the risk of placental dysfunction. J Obstet Gynaecol Can 2005; 27: 1095–1101.
Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P et al. Hypertensive diseases in pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326: 845–851.
Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC . High body mass index and hypertotal cholesterol emia: risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 543–550.
Harskamp RE, Zeeman GG . Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 2007; 334: 291–295.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Lei, Q., Lv, L., Zhang, B. et al. Ante-partum and post-partum markers of metabolic syndrome in pre-eclampsia. J Hum Hypertens 25, 11–17 (2011). https://doi.org/10.1038/jhh.2010.29
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2010.29